Despite significant advances in cancer therapy over the years, its complex pathological
process still represents a major health challenge when seeking effective treatment and …

To complement the existing treatment guidelines for all tumour types, ESMO organises
consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO …

Background This is an updated version of the original review published in Issue 4, 2004.
The use of concurrent chemotherapy and radiotherapy in non‐small cell lung cancer …

Background It is unknown whether combined chemoradiotherapy improves overall survival
in elderly patients with locally advanced non-small-cell lung cancer (NSCLC). The aim of …

Background Despite several randomised trials comparing radiotherapy alone with
concomitant radio-chemotherapy in patients with locally advanced non-small cell lung …

A randomised phase III study was performed comparing sequential (S) and concurrent (C)
chemo-radiotherapy (CRT) in non-small cell lung cancer (NSCLC) patients. METHODS: One …

Purpose We previously showed that individualized radiation dose escalation based on
normal tissue constraints would allow safe administration of high radiation doses with low …

Stage III nonsmall cell lung cancer (NSCLC) comprises about one-third of NSCLC patients
and is very heterogeneous with varying and mostly poor prognosis. It is also called …

Purpose This study is an update of a systematic review of health-related quality-of-life
(HRQOL) methodology reporting in non–small-cell lung cancer (NSCLC) randomized …

Lung cancer is the leading cause of cancer-related death in the United States and
approximately 85% of all lung cancers are classified as nonsmall cell (NSCLC). We here …